Latest News & Features
Americas
State sovereignty principles don’t give the Board of Regents of the University of Texas the right to bring a lawsuit in an improper venue, according to the US Court of Appeals for the Federal Circuit. 6 September 2019
Americas
Americans now hold less regard for big pharma than any other industry, according to a poll from US analytics company Gallup. 5 September 2019
Asia
Indian drugmaker Lupin and German pharma company Boehringer Ingelheim have formed an alliance to develop a therapy for patients with difficult-to-treat cancers. 5 September 2019
Big Pharma
CAR-T cells have achieved hugely-positive outcomes in treating forms of cancer that are otherwise difficult to treat. 5 September 2019
Americas
US-based Vertex Pharmaceuticals has announced it will pay $950 million to acquire Semma Therapeutics, a biotechnology company focused on researching a cure for Type 1 diabetes. 4 September 2019
Big Pharma
Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association. 3 September 2019
Biotechnology
An alliance of companies that use gene-editing technologies has released a bioethical framework, as controversy over gene-editing continues. 3 September 2019
Big Pharma
Nicole Jadeja, the former co-head of life sciences at Fieldfisher, has joined Pinsent Masons as a partner in its London office. 3 September 2019
Genetics
The World Health Organization has launched a global registry to track research on human genome editing. 3 September 2019
Generics
The US Court of Appeals for the Federal Circuit has ruled that claims in an Allergan patent detailing the results of a glaucoma treatment are material to its patentability, after an unsuccessful invalidation appeal brought by Sandoz. 30 August 2019